Delivery Order SPE2DB22D3501-SPE2DB25FWE62
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Sulfadiazine Cream with a ceiling value of $1,675.20. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by October 9, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, to supply Sulfamethoxazole-TMP DS tablets in quantities of 100 units to the Defense Logistics Agency's Medical Supply Chain. This non-competed, firm fixed-price delivery order carries a ceiling value of $2,014.35 with an ultimate completion date of July 31, 2025. The product will be delivered to the company's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Sulfamylon 8.5% Cream in 453.6 gram units, with a ceiling value of $2,379.52 and a completion date of May 12, 2023. The contract is a firm fixed-price arrangement and was not set aside for any specific business type, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,137.83 for Sulfamethoxazole-Trimethoprim (SULFA-TMP) DS 100S on June 4, 2025, with completion scheduled for July 2, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,179.81 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-TMP DS tablets (500 count) on September 15, 2025, with completion targeted for September 16, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.75 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sodium Tetrasulfate 3% 60mg/2ml in 2ml quantities. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,174.63 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for sulfamethoxazole-trimethoprim DS tablets (500 count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $2,906.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for sulfamethoxazole-trimethoprim double-strength tablets (500 count) with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sotradecol 1% vial 2ml pharmaceutical product. This firm fixed price delivery order, valued at $3,457.80, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award was made on a competitive basis with no...
- The Defense Logistics Agency (DLA) awarded a $9,830.02 delivery order to AmerisourceBergen Drug Corp for SOTRADECOL 1% Vial 2ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed-price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWE62Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,386.44 to AmerisourceBergen Drug Corp for Sod Sulfacet-Sulfur 10-5% Closure 340.2GM pharmaceutical product. This is a firm fixed price, non-set-aside contract awarded on June 26, 2025, with an ultimate completion date of June 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical federal medical procurement vendor serving military and veteran healthcare systems. The company maintains extensive federal contract relationships with the DLA Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for sulfacet-sulfur topical medication supports the broader pharmaceutical prime vendor program that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/26/25 |